Home › Funds › Arnhold LLC › BIO

Arnhold LLC position in BIO

BIO RAD LABS INC · Industrials

Arnhold LLC reported holding 55,568 shares of BIO (BIO RAD LABS INC) in its Q3 2026 13F filing — a position valued at US$21.0M, representing 1.50% of its reported portfolio and ranking #23 among its reported holdings. Arnhold LLC has disclosed BIO holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)55.57K sh
Reported value held$20.99M
Portfolio Weight1.50%
First reportedQ2 2025
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Arnhold LLC's BIO position evolved

Arnhold LLC first disclosed a stake in BIO in Q2 2025 at 34,784 shares (US$8.4M). The position peaked in Q3 2026 at 55,568 shares, worth US$21.0M. Across 6 filings, Arnhold LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 55,568 shares valued at US$21.0M. Notable position changes include a 30% increase in Q2 2026 (shares rose 29% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 34.78K $8.39M New
Q3 2025 34.78K $9.75M Hold
Q4 2025 34.78K $10.54M Hold
Q1 2026 42.90K $11.96M Add
Q2 2026 55.57K $16.32M Add
Q3 2026 55.57K $20.99M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BIO and 13F data

BIO (BIO RAD LABS INC) is a Industrials company. 25 other funds we track also report a position in BIO — the largest reported positions include First Eagle Investment Management (US$927.5M), ARIEL INVESTMENTS, LLC (US$298.1M), EARNEST PARTNERS LLC (US$214.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIO

All BIO fund holders →

FAQ

How long has Arnhold LLC held BIO?

Arnhold LLC has disclosed BIO holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Arnhold LLC's current position in BIO?

As of Q3 2026, Arnhold LLC holds 55.57K shares of BIO (BIO RAD LABS INC), valued at $20.99M, representing 1.50% of its reported portfolio and ranking #23.

Has Arnhold LLC been buying or selling BIO?

In the latest 13F filing (Q3 2026), Arnhold LLC held unchanged its position in BIO. The position peaked in Q3 2026 at 55.57K shares.

Which other funds hold BIO?

Other major institutional holders of BIO include First Eagle Investment Management, ARIEL INVESTMENTS, LLC, EARNEST PARTNERS LLC, among 25 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.